Who owns Aptevo Therapeutics Inc?
- CUSIP Number: 03835l504
Tip: Access positions for across all investors
Analyze quarterly positions in Aptevo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aptevo Therapeutics stock
Who bought or sold Aptevo Therapeutics Inc this quarter?
There are no current stakeholders of Aptevo Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Aptevo Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Sep 2025 | 300k | $435k |
| DRW Holdings | Sep 2025 | 132k | $191k |
| Virtu Financial | Sep 2025 | 38k | $56k |
| Colony | Sep 2025 | 10k | $15k |
| Advisor Group Holdings | Sep 2025 | 6.5k | $9.8k |
| UBS Group | Sep 2025 | 5.7k | $8.3k |
| Tower Research Capital | Sep 2025 | 1.4k | $2.1k |
| SBI Securities | Sep 2025 | 570.00 | $827.013000 |
| BlackRock | Sep 2025 | 1.00 | $1.000000 |
| Danske Bank A/s | Sep 2025 | 1.00 | $1.000000 |